[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334474-105":59,"doc-detail-334474-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","temporal-trend-in-hospitalizations-for-malignant-neoplasm-and-benign-neoplasm-a-nationwide-study-china-2004-2020","Temporal trend in hospitalizations for malignant neoplasm and benign neoplasm: a nationwide study, China, 2004– 2020","","The increasing cancer burden drives the need for reliable, time- and space-sensitive assessment of how tumor hospitalizations change across China. This nationwide study analyzes trends in hospitalization rates, in-hospital mortality, length of stay (LOS), and medical costs for malignant and benign neoplasms. Data come from China Health Statistical Yearbooks spanning 2004–2020. Cochran-Armitage tests evaluate temporal changes, and a linear model with continuous variables tests the trend. Malignant and benign hospitalization rates increased, while in-hospital mortality and LOS decreased, with narrowing urban–rural gaps in hospitalization rates.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/temporal-trend-in-hospitalizations-for-malignant-neoplasm-and-benign-neoplasm-a-nationwide-study-china-2004-2020/334474/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/temporal-trend-in-hospitalizations-for-malignant-neoplasm-and-benign-neoplasm-a-nationwide-study-china-2004-2020/334474.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What outcomes did the study evaluate for malignant and benign neoplasms?","Question",{"text":112,"@type":113},"The study assessed hospitalization rate, in-hospital mortality, length of stay (LOS), and medical costs for both malignant and benign neoplasms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were temporal trends tested in the study?",{"text":117,"@type":113},"Temporal trends in hospitalization rates and in-hospital mortality rates were evaluated using the Cochran-Armitage Test, and a linear model with continuous variables was used to test trend in other measures.",{"name":119,"@type":110,"acceptedAnswer":120},"What direction of change was observed in malignant and benign neoplasm hospitalization rates and outcomes?",{"text":121,"@type":113},"Hospitalization rates increased for both malignant and benign neoplasms, while in-hospital mortality and LOS decreased substantially over the study period.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334474,1790012954,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":4},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","Zhang et al. BMC Cancer (2024) 24:154 [https://doi.org/10.1186/s12885-024-11866-x](https://doi.org/10.1186/s12885-024-11866-x)  \nBMC Cancer  \nRESEARCH Open Access  \nTemporal trend in hospitalizations for malignant neoplasm and benign neoplasm: a nationwide study, China, 2004– 2020  \nXinqiang Zhang 1, Yuanyuan Li2, Guifang Zhang 1, Changsheng Ma 1, Bo Liu 1 and Yong Yin 1*  \nAbstract  \nThe increasing cancer burden calls for reliably assessed changes in the hospitalizations for tumors over time and space in China. This study evaluated trends in hospitalization rate, in-hospital mortality, length of stay (LOS), and medical costs for malignant and benign neoplasms. Data were derived from China Health Statistical Yearbooks from 2004 to 2020. Temporal trends in hospitalization rates and in-hospital mortality rates were assessed through the Cochran-Armitage Test. We used the linear model with continuous variables to test for the trend. The malignant neoplasm hospitalization rate increased from 1. 1‰ to 5. 8‰ and the benign neoplasm increased from 1. 0‰ to 2. 0‰. The in-hospital mortality rate due to malignant neoplasm and benign neoplasm decreased from 5.11 to 2. 87%(P for trend \u003C 0. 001) and 0.14–0. 01%(P for trend \u003C 0. 001), respectively. Among all patients hospitalized with malignant neoplasm, the average cost per hospitalization significantly increased during the study period (P for trend \u003C 0. 001), adjusted for the Consumer Price Index. However, the average LOS gradually decreased (P for trend \u003C 0. 001) . In line with the trend of malignant neoplasm, the average cost per hospitalization increased significantly among all patients hospitalized for benign neoplasm (P for trend \u003C 0. 001), and the average LOS showed a steady downward trend (P for trend \u003C 0. 001) . We found upward trends in hospitalization rates, and medical costs in neoplasms. By contrast, substantial decreases in in-hospital mortality and LOS. The hospitalization rate gap between urban and rural areas is narrowed.  \n*Correspondence: Yong Yin [yongyinsd@163.com](yongyinsd@163.com)  \n1Department of Radiophysical Technology, Shandong Cancer Hospital, No.440, Jiyan Road, Jinan City, Shandong province 250000, China 2Statistical Analysis Department, Clinical Research Center, Qilu Pharmaceutical Co., Ltd, 8888 Lvyou Street, Jilin 250102, China  \nIntroduction  \nCancer is one of the major public health problems and is a leading cause of death, placing an increasing economic burden on cancer in China over the past half-century [1–3]. In 2020, China alone accounted for a quarter of the world’s cancer deaths [4]. Due to rapid economic and social development, the major cancer pattern in China is changing from a developing country to a developed country. There was a huge variation in cancer incidence and mortality in China, the United States, and the United Kingdom in 2020. The incidence of cancers in China (204.80 per 100,000 population) was lower than those in  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.o","cbCair11P4dwXJRn","https://ap.wps.com/l/cbCair11P4dwXJRn","pdf",2784968,"English","# Abstract\n## Study design and data sources\n## Key findings on hospitalization rates, mortality, LOS, and costs\n## Interpretation of trends across patient subgroups","[{\"question\":\"What outcomes did the study evaluate for malignant and benign neoplasms?\",\"answer\":\"The study assessed hospitalization rate, in-hospital mortality, length of stay (LOS), and medical costs for both malignant and benign neoplasms.\"},{\"question\":\"How were temporal trends tested in the study?\",\"answer\":\"Temporal trends in hospitalization rates and in-hospital mortality rates were evaluated using the Cochran-Armitage Test, and a linear model with continuous variables was used to test trend in other measures.\"},{\"question\":\"What direction of change was observed in malignant and benign neoplasm hospitalization rates and outcomes?\",\"answer\":\"Hospitalization rates increased for both malignant and benign neoplasms, while in-hospital mortality and LOS decreased substantially over the study period.\"}]","Temporal trend in hospitalizations for malignant neoplasm and benign neoplasm: a nationwide study, China, 2004– 2020 | PDF",1790006799]